IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has won £1.3 million of new contracts, including work to validate a blood-based Alzheimer's biomarker test for FDA clearance and an extended Huntington's disease trial. CEO Bram Goorden says the wins hit three key components of the company's growth strategy. Read more
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) has reported its first commercial revenue from its Stereax solid-state battery range after delivering an initial batch to US partner Cirtec Medical. The company is also expanding its larger Goliath battery into defence and consumer markets, including a joint development programme with Brompton for next-generation e-bikes. Read more
EMV Capital (AIM:EMVC, FRA:NTK1) portfolio company AMR Bio is preparing its XF-73 antimicrobial for a phase III trial targeting post-surgical infections, backed by FDA Fast Track status and UK Accelerated Access designation. Peak US sales potential is estimated at up to $1 billion a year. Read more
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF, FRA:VD5N) expects to raise $2.275 million from selling non-core Wyoming acreage, taking total value generated from its August 2025 acquisition to over $8.7 million, well above the $7.3 million originally paid. Read more
Metals One PLC (AIM:MET1, FRA:HT7, OTCQB:MTOPF) says its 35%-owned NovaCore Uranium is raising at least $1.25 million ahead of a targeted Q3 IPO, with funds earmarked for pre-drilling work at its New Mexico uranium project. The financing values NovaCore at $6.7 million, above Metals One's average entry price. Read more
Bradda Head Lithium Ltd (AIM:BHL, OTC:BHLIF, TSX-V:BHLI, FRA:8CD1) has identified three priority drilling targets at its San Domingo lithium project in Arizona following geochemical analysis by SRK Consulting. All three areas have BLM-approved exploration permits ready to go. Read more
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.
